With reference to its letter dated August 19, 2020 enclosing the Postal Ballot Notice along with the Explanatory Statement seeking the consent of the Members by way of passing special/ordinary resolutions vide remote e-voting with respect to the following items of business: Consolidation of shareholding in Provet Veteriner Urunleri San. Ve Tic. A. S., Turkey (Provet) and to make Provet a wholly owned subsidiary of the Company, sale of investments made by the Company in the equity shares of Strides Pharma Science, and sale of Investments made by the Company in the equity shares of Strides Pharma Science to Related Parties. In connection with the above and pursuant to Regulation 44(3) of the Listing Regulations, Sequent Scientific has informed that the aforesaid resolutions have been passed by the Members of the Company by requisite majority. The company has enclosed the Voting Results (Annexure A) and Report of the Scrutinizer on remote e-voting in accordance with Rule 22 of the Companies (Management and Administration) Rules, 2014.
The above information is a part of company’s filings submitted to BSE.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1504.25 |
Dr. Reddys Lab | 6263.70 |
Cipla | 1406.25 |
Zydus Lifesciences | 948.20 |
Lupin | 1615.85 |
View more.. |